Safety of COVID-19 vaccines
- PMID: 37045709
- PMCID: PMC10083197
- DOI: 10.1016/j.ejim.2023.04.009
Safety of COVID-19 vaccines
Conflict of interest statement
Declaration of Competing Interest The authors declare they have no conflict of interest.
Comment on
-
Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe.Eur J Intern Med. 2023 Jun;112:122-125. doi: 10.1016/j.ejim.2023.02.014. Epub 2023 Feb 13. Eur J Intern Med. 2023. PMID: 36792428 Free PMC article. No abstract available.
References
-
- EMA. EMA recommends first COVID-19 vaccine for authorisation in the EU [press release]. 21/12/2020 2020. Available from https://www.ema.europa.eu/en/news/ema-recommends-first-covid-19-vaccine-....
-
- EMA. Safety of COVID-19 vaccines 2023 [Available from: https://www.ema.europa.eu/en/human-regulatory/overview/public-health-thr....
-
- Dal Pan G.J., Lindquist M., Gelperin K., Brian S.E.K., Strom L., Hennessy S. John Wiley & Sons, Ltd; 2012. Postmarketing spontaneous pharmacovigilance reporting systems; pp. 137–157.
-
- Council Directive Council directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products. Union. Off J Eur Communities. 1965
-
- Laroche M.L., Batz A., Geniaux H., Fechant C., Merle L., Maison P. Pharmacovigilance in Europe: place of the pharmacovigilance risk assessment committee (PRAC) in organisation and decisional processes. Therapie. 2016;71(2):161–169. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
